The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study
Open accessAbstract
PURPOSE: The COVID-19 pandemic affected health care systems globally and resulted in the interruption of usual care in many health care facilities, exposing vulnerable patients with cancer to significant risks. Our study aimed to evaluate the impact of this pandemic on cancer care worldwide. METHODS: We conducted a cross-sectional study using a validated web-based questionnaire of 51 items. The questionnaire obtained information on the capacity and services offered at these centers, magnitude of disruption of care, reasons for disruption, challenges faced, interventions implemented, and the estimation of patient harm during the pandemic. RESULTS: A total of 356 centers from 54 countries across six continents participated between April 21 and May 8, 2020. These centers serve 716,979 new patients with cancer a year. Most of them (88.2%) reported facing challenges in delivering care during the pandemic. Although 55.34% reduced services as part of a preemptive strategy, other common reasons included an overwhelmed system (19.94%), lack of personal protective equipment (19.10%), staff shortage (17.98%), and restricted access to medications (9.83%). Missing at least one cycle of therapy by > 10% of patients was reported in 46.31% of the centers. Participants reported patient exposure to harm from interruption of cancer-specific care (36.52%) and noncancer-related care (39.04%), with some centers estimating that up to 80% of their patients were exposed to harm. CONCLUSION: The detrimental impact of the COVID-19 pandemic on cancer care is widespread, with varying magnitude among centers worldwide. Additional research to assess this impact at the patient level is required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105924 · Cited by 6,068
Ranney, M. L., Griffeth, V., & Jha, A. K. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2006141 · Cited by 2,018
Defining the Epidemiology of Covid-19 — Studies Needed
Lipsitch, M., Swerdlow, D. L., & Finelli, L. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2002125 · Cited by 1,248
Sourcing Personal Protective Equipment During the COVID-19 Pandemic
Livingston, E., Desai, A., & Berkwits, M. (2020) · JAMA · doi:10.1001/jama.2020.5317 · Cited by 637
The impact of the COVID-19 pandemic on cancer care
Richards, M., Anderson, M., Carter, P., Ebert, B. L., & Mossialos, E. (2020) · Nature Cancer · doi:10.1038/s43018-020-0074-y · Cited by 587
The COVID-19 Pandemic: Effects on Low- and Middle-Income Countries
Bong, C.-L., Brasher, C., Chikumba, E., McDougall, R., Mellin-Olsen, J., & Enright, A. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004846 · Cited by 438
Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic
Hanna, T. P., Evans, G. A., & Booth, C. M. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0362-6 · Cited by 400
Closing the Rural Cancer Care Gap: Three Institutional Approaches
Levit, L. A., Byatt, L., Lyss, A. P., Paskett, E. D., Levit, K., Kirkwood, K., Schenkel, C., & Schilsky, R. L. (2020) · JCO Oncology Practice · doi:10.1200/op.20.00174 · Cited by 331
Caring for patients with cancer in the COVID-19 era
van de Haar, J., Hoes, L. R., Coles, C. E., Seamon, K., Fröhling, S., Jäger, D., Valenza, F., de Braud, F., De Petris, L., Bergh, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0874-8 · Cited by 330
Triage of Scarce Critical Care Resources in COVID-19 An Implementation Guide for Regional Allocation
Maves, R. C., Downar, J., Dichter, J. R., Hick, J. L., Devereaux, A., Geiling, J. A., Kissoon, N., Hupert, N., Niven, A. S., King, M. A., et al. (2020) · Chest · doi:10.1016/j.chest.2020.03.063 · Cited by 278
Oncology Practice During the COVID-19 Pandemic
Schrag, D., Hershman, D. L., & Basch, E. (2020) · JAMA · doi:10.1001/jama.2020.6236 · Cited by 252
Global resource shortages during COVID-19: Bad news for low-income countries
McMahon, D. E., Peters, G. A., Ivers, L. C., & Freeman, E. E. (2020) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0008412 · Cited by 235
Conserving Supply of Personal Protective Equipment—A Call for Ideas
Bauchner, H., Fontanarosa, P. B., & Livingston, E. H. (2020) · JAMA · doi:10.1001/jama.2020.4770 · Cited by 200
The official French guidelines to protect patients with cancer against SARS-CoV-2 infection
You, B., Ravaud, A., Canivet, A., Ganem, G., Giraud, P., Guimbaud, R., Kaluzinski, L., Krakowski, I., Mayeur, D., Grellety, T., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30204-7 · Cited by 187
Members of Steering Committee, S. O. G. H., Qian, X., Ren, R., Wang, Y., Guo, Y., Fang, J., Wu, Z.-D., Liu, P.-L., & Han, T.-R. (2020) · Infectious Diseases of Poverty · doi:10.1186/s40249-020-00650-1 · Cited by 173
Effect of the COVID-19 pandemic on cancer treatment and research
Saini, K. S., Heras, B. D. L., de Castro, J., Venkitaraman, R., Poelman, M., Srinivasan, G., Saini, M. L., Verma, S., Leone, M., Aftimos, P. G., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30123-x · Cited by 150
Self-citationTelemedicine for Cancer Care in the Time of COVID-19
Royce, T. J., Sanoff, H. K., & Rewari, A. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.2684 · Cited by 122
Marron, J. M., Joffe, S., Jagsi, R., Spence, R., & Hlubocky, F. J. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00960 · Cited by 121
COVID-19: impact on cancer workforce and delivery of care
Mayor, S. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30240-0 · Cited by 102
COVID-19 pandemic in sub-Saharan Africa: preparedness, response, and hidden potentials
Osseni, I. A. (2020) · Tropical Medicine and Health · doi:10.1186/s41182-020-00240-9 · Cited by 98
Silbermann, M., Pitsillides, B., Al-Alfi, N., Omran, S., Al-Jabri, K., Elshamy, K., Ghrayeb, I. M., Livneh, J., Daher, M., Charalambous, H., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt265 · Cited by 93
Personal protective equipment needs in the USA during the COVID-19 pandemic
Gondi, S., Beckman, A. L., Deveau, N. D., Raja, A. S., Ranney, M. L., Popkin, R., & He, S. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31038-2 · Cited by 79
Jazieh, A. R., Hadab, A. A., Olayan, A. A., Alhejazi, A., Safi, F. A., Qarni, A. A., Farooqui, F., Mutairi, N. A., & Alenazi, T. H. (2020) · JCO Global Oncology · doi:10.1200/go.20.00063 · Cited by 48
Self-citationLow- and middle-income countries face up to COVID-19
Shuchman, M. (2020) · Nature Medicine · doi:10.1038/d41591-020-00020-2 · Cited by 39
COVID-19 and cancer: do we really know what we think we know?
Robinson, A. G., Gyawali, B., & Evans, G. A. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0394-y · Cited by 35
Cancer disparities in the COVID‐19 era
Hoehn, R. S., & Zureikat, A. H. (2020) · Journal of Surgical Oncology · doi:10.1002/jso.26043 · Cited by 16
Pharmacy and Therapeutics Committee Preparedness Plan for COVID-19
Esba, L. C. A., Alabdulkarim, H. A., Alrushidan, A., & Harbi, M. A. (2020) · Global Journal on Quality and Safety in Healthcare · doi:10.36401/jqsh-20-9 · Cited by 8
Cited by
Massarweh, A., Eliakim-Raz, N., Stemmer, A., Levy-Barda, A., Yust-Katz, S., Zer, A., Benouaich-Amiel, A., Ben-Zvi, H., Moskovits, N., Brenner, B., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.2155 · Cited by 265
Impact of COVID-19 on cancer care in India: a cohort study
Ranganathan, P., Sengar, M., Chinnaswamy, G., Agrawal, G., Arumugham, R., Bhatt, R., Bilimagga, R., Chakrabarti, J., Chandrasekharan, A., Chaturvedi, H. K., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00240-0 · Cited by 159
Rine, S., Lara, S. T., Bikomeye, J. C., Beltrán-Ponce, S., Kibudde, S., Niyonzima, N., Lawal, O. O., Mulamira, P., & Beyer, K. M. (2023) · Journal of Global Health · doi:10.7189/jogh.13.06048 · Cited by 16
Gaudio, E., Ammar, N., Gunturkun, F., Akkus, C., Brakefield, W., Wakefield, D. V., Pisu, M., Davis, R., Shaban-Nejad, A., & Schwartz, D. L. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.09.073 · Cited by 11
“Public health responses to the COVID-19 pandemic (eg, social distancing and local “stay at home” orders) and patient treatment avoidance severely compromised cancer care in the United States (US)(1) and abroad.(2) There has been well-documented deferment of cancer screenings and diagnoses since the beginning of the pa…”
Metadata
- Authors
- Jazieh, A. R., Akbulut, H., Curigliano, G., Rogado, A., Alsharm, A. A., Razis, E. D., Mula-Hussain, L., Errihani, H., Khattak, A., De Guzman, R. B., Mathias, C., Alkaiyat, M. O. F., Jradi, H., Rolfo, C., & on behalf of the International Research Network on COVID-19 Impact on Cancer Care
- Venue
- JCO Global Oncology
- Published
- 2020-11
- Volume
- 6
- Issue
- 6
- Pages
- 1428-1438
- ISSN
- 2687-8941 (ISSN-L)
- OpenAlex
- W3088678426
- Cited by
- 277
- References
- 31
- FWCI
- 17.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.